Etidaligide clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How each study uses etidaligide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- AsiDNA
- 3
Studies by the year they started
3 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Studies
Open first, then newest update. How each study uses etidaligide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid TumorsCompletedPhase 1/2Valerio TherapeuticsNCT05700669Written as AsiDNA
- AsiDNA Children, Adolescents and Young AdultsTerminatedPhase 1/2Institut CurieNCT05394558Written as AsiDNA
- AsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid TumorsCompletedPhase 1Valerio TherapeuticsNCT03579628Written as AsiDNA
Given beside what is tested · 1 — etidaligide is usual care or a partner of the new treatment
Codes
What other systems call etidaligide · ClinicalTrials.gg INT018247
- UNII (FDA) VHB1T5I5S1ETIDALIGIDEOne source FDA
- NCI Thesaurus C169969EtidaligideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | VHB1T5I5S1 | ETIDALIGIDE | One source FDA |
| NCI Thesaurus | C169969 | Etidaligide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.